From: Tazia Smith Sent: 4/22/2014 4:16:17 PM To: jeevacatio CC: Paul ' Vahe Stepanian Vinit Sahni Subject: Re: Biotech Update... Gilead beat, shares halted (CJ Classification: Confidential Jeffrey - sure you see this, just making sure, Gilead shares are halted in the after-market following a significant top and bottom-line earnings beat ($1.48 vs $0.92 cons eps, 55bn on the topline vs. expecations of 53.96bn) as you know, you're long 8100 shares at an average price of $79.41, stock closed today at $72.86, just reported. Shares expected to re-open at 4:30pm GILD US $ At 16:00 Pz- tiv 71.60 morl.e..-. SI Save As 141 Acti ons . 0:a!!=ilin 77' '7 7 ,1 If • • Max pally v + Track ., Annotate p g) if • Last Price 72.86 T High on 02/25/14 83.95 ri 4- Average 66.0548 I Low on 06/21/13 48.83 t 'Cia2 • Volum I e 23.969M Jun Sep Dec Mar 2013 2014 72./36 / 72 .8- Indit - 6$ Table Une that - or-- - OEM= C,=XIIIIIMII" CS" 4 :":" 5. runt .. . 7ttez. 16 E. nt GI ,- News ZOOM 85 / \AV 'P. \ 20 k ri—VI ) it v‘li 1 4 7C 72.86 65 55 SO 40M 23,969M 0 Froo Tara SmAh clb dbcom To. Cc Paul Morris, Va Date 04/02/2014 03:42 PM Sub'. — t Biotech Update... CC] Classification: Confidential Jeffrey - Biotech forming a base to some extent (strong market backdrop, clearly) - you're up $906k on your basket excluding the Ariad (outlier due to M&A prospects vs. group drivers) 1-mo price history charts below. CONFIDENTIAL — PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0 123735 CONFIDENTIAL SDNY_GM_00269919 EFTA01461593